Purchases and Sales Made in Q2 2024 in Allovir, Inc. (ALVR)
This table provides information about the institutional ownership of Allovir, Inc. (ALVR) during Q2 2024. The information is specifically focused on institutions that hold shares of Allovir, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-284K- 80.22% |
$204K - $233K
|
70K
$38.5K
|
|
|
Aug 14, 2024
Q2 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-394K- 45.33% |
$284K - $323K
|
476K
$262K
|
|
|
Aug 06, 2024
Q2 2024
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-411K- 25.92% |
$296K - $337K
|
1.18M
$647K
|
|
|
Aug 09, 2024
Q2 2024
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-626K- 49.17% |
$451K - $514K
|
647K
$356K
|
|
|
Aug 14, 2024
Q2 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-956K- 81.12% |
$688K - $784K
|
222K
$122K
|
|
|
Aug 13, 2024
Q2 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-2.75M- 81.27% |
$1.98M - $2.26M
|
634K
$349K
|